316
Views
1
CrossRef citations to date
0
Altmetric
Clinical features - Original research

Characteristics of tuberculosis-related deaths and risk factors: a retrospective cohort study in Samsun province of Turkey

ORCID Icon, ORCID Icon & ORCID Icon
Pages 217-223 | Received 05 Aug 2021, Accepted 06 Jan 2022, Published online: 26 Jan 2022

References

  • Dirlikov E, Raviglione M, Scano F. Global Tuberculosis Control: toward the 2015 Targets and Beyond. Ann Intern Med. 2015;163(1):52–58.
  • World Health Organization. Global tuberculosis report 2020. 2020 cited 2021 Mar 28. https://www.who.int/publications-detail-redirect/9789240013131
  • Republic of Turkey Ministry of Health. The Guideline of Tuberculosis Diagnosis and Treatment 2019. Ankara Turkey: cited 2021 May 05. https://hsgm.saglik.gov.tr/tr/tuberkuloz-haberler/t%C3%BCberk%C3%BCloz-tan%C4%B1-ve-tedavi-rehberi.html
  • Sengul A, Akturk UA, Aydemir Y, et al. Factors affecting successful treatment outcomes in pulmonary tuberculosis: a single-center experience in Turkey, 2005-2011. J Infect Developing Countries. 2015;9(8):821–828.
  • Republic of Turkey Ministry of Health. Tuberculosis active surveillance criteria. cited 2021 May 14. http://tuberkuloz.saglik.gov.tr
  • WHO Tuberculosis Programme. WHO Tuberculosis Programme: framework for effective tuberculosis control. World Health Organization; 1994 cited 2021 May 15. https://apps.who.int/iris/handle/10665/58717
  • Birlie A, Tesfaw G, Dejene T, et al. Time to Death and Associated Factors among Tuberculosis Patients in Dangila Woreda, Northwest Ethiopia. PLoS One. 2015;10(12):e0144244.
  • Kwon YS, Kim YH, Song JU, et al. Risk factors for death during pulmonary tuberculosis treatment in Korea: a multicenter retrospective cohort study. J Korean Med Sci. 2014;29(9):1226–1231.
  • Abedi S, Moosazadeh M, Afshari M, et al. Determinant factors for mortality during treatment among tuberculosis patients: cox proportional hazards model. Indian J Tubercul. 2019;66(1):39–43.
  • World Health Organization. Definitions and reporting framework for tuberculosis – 2013 revision: updated December 2014 and January 2020. World Health Organization; 2013 cited 2021 May 14. https://apps.who.int/iris/handle/10665/79199
  • Republic of Turkey Ministry of Health. Death Notification System Circular 2012/ 05. Presidency of Public Health Institution of Turkey; 2012 cited 2021 Mar 03. https://www.saglik.gov.tr/TR,11167/olum-bildirim-sistemiobs-genelgesi.html
  • Republic of Turkey Ministry of Health. Turkish Public Health Institution, Department of Tuberculosis. Tuberculosis War in Turkey 2014 Report, Ankara: 2015 cited 2021 May 22. https://hsgm.saglik.gov.tr/depo/birimler/tuberkuloz_db/dosya/raporlar/Turkiyede_Verem_Savasi_2014_Raporu.pdf?type=file
  • Erbes R, Oettel K, Raffenberg M, et al. Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J. 2006;27(6):1223–1228.
  • Lin SM, Wang TY, Liu WT, et al. Predictive factors for mortality among non-HIV-infected patients with pulmonary tuberculosis and respiratory failure. Int J Tuberc Lung Dis. 2009;13(3):335–340.
  • Silva DR, Menegotto DM, Schulz LF, et al. Mortality among patients with tuberculosis requiring intensive care: a retrospective cohort study. BMC Infect Dis. 2010;10(1):1–7.
  • Xie Y, Han J, Yu W, et al. Survival Analysis of Risk Factors for Mortality in a Cohort of Patients with Tuberculosis. Can Respir J. 2020;2020:1654653.
  • Holden IK, Lillebaek T, Andersen PH, et al. Characteristics and predictors for tuberculosis related mortality in Denmark from 2009 through 2014: a retrospective cohort study. Plos One. 2020;15(6):e0231821.
  • Lin YS, Yen YF. Determinants of mortality before start of and during tuberculosis treatment among elderly patients: a population-based retrospective cohort study. Age Ageing. 2015;44(3):490–496.
  • Rajagopalan S. Tuberculosis in Older Adults. Clin Geriatr Med. 2016;32(3):479–491.
  • Kwon YS, Chi SY, Oh IJ, et al. Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study. BMC Infect Dis. 2013;13(1):121.
  • Adamu AL, Gadanya MA, Abubakar IS, et al. High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study. BMC Infect Dis. 2017;17(1):170.
  • Tuberculosis War in Turkey. Report. In: Republic of Turkey Ministry of Health Publication No: 1109. Ankara: 2018.
  • Filiz KA, Levent D, Emel E, et al. Characteristics of Active Tuberculosis Patients Requiring Intensive Care Monitoring and Factors Affecting Mortality. Tuberc Respir Dis (Seoul). 2016;79(3):158–164.
  • Hannah HA, Miramontes R, Gandhi NR. Sociodemographic and Clinical Risk Factors Associated With Tuberculosis Mortality in the United States, 2009-2013. Public Health Rep. 2017;132(3):366–375.
  • Chung-Delgado K, Guillen-Bravo S, Revilla-Montag A, et al. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors. PloS One. 2015;10(3):e0119332.
  • Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. 2011;15(7):871–885.
  • Sreeramareddy CT, Qin ZZ, Satyanarayana S, et al. Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis. 2014;18(3):255–266.
  • Needham DM, Foster SD, Tomlinson G, et al. Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health. 2001;6(4):256–259.
  • Hussen A, Biadgilign S, Tessema F, et al. Treatment delay among pulmonary tuberculosis patients in pastoralist communities in Bale Zone, Southeast Ethiopia. BMC Res Notes. 2012;5(1):320.
  • Türkkani MH, Özdemir T, Ç Ö. Determination of related factors about diagnostic and treatment delays in patients with smear-positive pulmonary tuberculosis in Turkey. Turk J Med Sci. 2020;50(5):1371–1379.
  • World Health Organization. Epidemiology. Global Tuberculosis Control 2016. Epidemiology, Strategy, Financing. Geneva: WHO Report; 2016 cited 2021 May 12. https://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf
  • Kurtaran B, Nazik S, Ulu A, et al. HIV enfeksiyonu ve tüberküloz birlikteliğinin değerlendirilmesi. Mediterr J Infec Microbes Antimicrob 2015;4:4. (in Turkish.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.